Australian Clinical Labs
ACL.AX
#7699
Rank
A$0.53 B
Marketcap
A$2.79
Share price
2.20%
Change (1 day)
-22.78%
Change (1 year)

Revenue for Australian Clinical Labs (ACL.AX)

Revenue in 2025: A$0.73 Billion

According to Australian Clinical Labs's latest financial reports the company's current revenue (TTM ) is A$0.69 Billion. In 2025 the company made a revenue of A$0.73 Billion an increase over the revenue in the year 2024 that were of A$0.68 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Australian Clinical Labs from 2021 to 2025

Annual revenue

Year Revenue Change
2025A$0.73 B6.73%
2024A$0.68 B-0.34%
2023A$0.69 B-30.04%
2022A$0.98 B54.26%
2021A$0.64 B